Cargando…
Impact of epoetin β on quality of life in patients with malignant disease
This open-label, prospective study was conducted to compare the impact of epoetin β vs standard care on quality of life (QoL) in anaemic patients with lymphoid or solid tumour malignancies. A total of 262 anaemic patients (haemoglobin [Hb]⩽11 g dl(−1)) were randomised to a 12-week treatment with s.c...
Autores principales: | Boogaerts, M, Coiffier, B, Kainz, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376376/ https://www.ncbi.nlm.nih.gov/pubmed/12671693 http://dx.doi.org/10.1038/sj.bjc.6600801 |
Ejemplares similares
-
Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis
por: Aapro, M, et al.
Publicado: (2006) -
Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease
por: Fishbane, Steven, et al.
Publicado: (2019) -
The Use of Epoetin-α in Revision Knee Arthroplasty
por: Delasotta, Lawrence A., et al.
Publicado: (2012) -
Quality of Original and Biosimilar Epoetin Products
por: Brinks, Vera, et al.
Publicado: (2010) -
Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events
por: Aapro, M, et al.
Publicado: (2009)